Clinical trials
Completed Drug-Related Side Effects and Adverse Reactions trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2005 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 2 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Hospital of Eastern Ontario | 2 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 2 |
| University of British Columbia | 2 |
| Alliance for Clinical Trials in Oncology | 1 |
| Canadian Network for Observational Drug Effect Studies, CNODES | 1 |
| Children's Oncology Group | 1 |
| Dana-Farber Cancer Institute | 1 |
| Herbert Irving Comprehensive Cancer Center | 1 |
| Jessica Burjorjee, MD, FRCPC | 1 |
| McGill University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Drug-Related Side Effects and Adverse Reactions | 19 |
| Leukemia | 3 |
| Frailty | 2 |
| Lung Neoplasms | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Acute Kidney Injury | 1 |
| Agnosia | 1 |
| Anemia | 1 |
| Bipolar Disorder | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.